Stereotaxis is a medical - instruments & supplies company in the healthcare sector trading on AMEX, led by CEO David Leo Fischel, with a market cap of $190.1M.
Common questions about Stereotaxis
Stereotaxis is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $8.8M.
Stereotaxis has approximately 122 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.